Pharma Co. Can Get D&O Coverage For Securities Suit

A pharmaceutical company that developed a drug for rare genetic blood disorders is covered under a recent directors and officers policy for a securities class action, a Delaware state court ruled, rejecting...

Already a subscriber? Click here to view full article